Immunosuppressive Drugs in Heart Transplantation-Reference-Cited by-同舟云学术

Immunosuppressive Drugs in Heart Transplantation

Published:2019-04-02 Issue: Volume: Page:83-147
ISSN:1879-6648
Container-title:Frontiers in Cardiovascular Drug Discovery: Volume 4
language:
Short-container-title:

Author:

Apikoglu-Rabus Sule¹,Rabus Murat B.²,Umar Rashida Muhammad¹

Affiliation:

1. Marmara University Faculty of Pharmacy, Clinical Pharmacy Department, Istanbul, Turkey

2. Kartal Kosuyolu Higher Specialization Training and Research Hospital, Cardiovascular Surgery Department, Istanbul, Turkey

Abstract

Congestive heart failure affects 23 million people worldwide [1]. Cardiac transplantation provides a lifesaving treatment for patients with end-stage heart disease. It offers a longer life with a higher quality to those who have no other treatment alternative. Although cardiac transplantation offers a relief from heart immunosuppression. The goal of immunosuppression immediately following surgery is to prevent hyperacute and acute rejections. Transplantation immunosuppression must be balanced in order to prevent rejection while minimizing the serious adverse effects of therapy including life-threatening infections and malignancies. Immunosuppressive regimens are classified as induction, maintenance, or anti-rejection regimens. Induction regimens consist of intense early post-operative immunosuppression while maintenance regimens are used indefinitely for prevention of acute and chronic rejection. This chapter will review the induction and maintenance immunosuppressive regimens used in heart transplantation with summaries of selected literature as well as the most common complications of these therapies and significant drug-drug interactions.

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference188 articles.

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics2011 update: a report from the American Heart Association. Circulation 2011; 123(4): e18-e209.

2. Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant 2015; 34(10): 1244-54.

3. Abrahams Z, Mullens W, Boyle A. Cardiac transplantation. In: Griffin BP, Topol EJ, Eds. Manual of cardiovascular medicine. 3rd ed. PA, USA: Lippincott Williams & Wilkins Philadelphia 2009; pp. 171-90.

4. 2009 annual report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008. U.S. Department of Health and Human services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD. Available from: http://www.ustransplant.org/annual_reports/current.[accessed 1st Feb 2014].

5. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report2010. J Heart Lung Transplant 2010; 29(10): 1089-103.